TAK
Takeda Pharmaceutical Company LWhen TAK passed all Ten ChecksTakeda Pharmaceutical Company L
history · not a forecastOver the past 10 years, TAK has passed all Ten Checks on 9 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +6.4% in May 2017, peaked day 16.
- Sep 2025+0.3% -6.4%
- Mar 2024+1.2% -6.3%
- Mar 2023+5.6% -0.2%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about TAK’s checks
How many technical checks does TAK pass right now?
As of the Aug 13, 2026 close, TAK passes 6 of 10 fixed technical checks — the checks not passing: pulled back to support, not overextended, stop distance within range, adequate stop room.
Why does TAK fail the "stop distance within range" check?
A stop at $17.34 is only 0.3% below TAK's price — tighter than the 2% floor, so the risk check fails (too little room to work). It passes once the stop sits 2–8% below price.
What price would change TAK's check count?
The nearest flip level is "outperforming the market" fails on a close below $17.34. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.